MRKR · Marker Therapeutics, Inc.
$1.14
+0.03 (+2.70%)
At close · Aug 14
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding our ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$19.01M
Shares
16.67M
Marker Therapeutics, Inc. Earnings Call Transcripts
Every quarterly earnings call for Marker Therapeutics, Inc. (MRKR) — the full transcript with speaker labels, the audio replay, AI call highlights and a management-tone score, plus the matching 8-K earnings release and the quarter's 10-Q or 10-K. Investor days and conferences appear here too.
Earnings call
FY21 · Q3
2021-11-10
Marker Therapeutics, Inc. Q3 FY2021 Earnings Call
Diluted EPS
$-1.50
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-12
Marker Therapeutics, Inc. Q1 FY2021 Earnings Call
Diluted EPS
$-1.60
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q3
2020-11-09
Marker Therapeutics, Inc. Q3 FY2020 Earnings Call
Revenue
$
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-11
Marker Therapeutics, Inc. Q1 FY2020 Earnings Call
Results not yet reported
Audio
Transcript
Slides
8-K10-Q
Showing 1–4 of 4 earnings calls
Key facts
CIK
1094038
CUSIP
57055L206
13F (30d)
34 filings
34 filers
Visit website
Investor relations